Form 4: ICU Medical Executive Ben Sousa Reports Stock Transactions

Ben Sousa, Chief Information Officer of ICU Medical, reports the vesting and subsequent disposal of restricted stock units and performance-based restricted stock units.

Summary

• Ben Sousa, the Chief Information Officer of ICU Medical, reported transactions involving the company's stock on March 7th and 8th, 2024.
• These transactions involved the vesting of restricted stock units (RSUs) and performance-based restricted stock units (PRSUs).
• Some of the vested shares were then disposed of to cover tax obligations.
• On March 7th, 429 RSUs vested and 159 shares were disposed of at a price of $105.39.
• Also on March 7th, 2,574 PRSUs vested and 918 shares were disposed of at a price of $105.39.
• On March 8th, 674 RSUs vested and 240 shares were disposed of at a price of $104.52.
• The PRSUs were granted on March 7, 2022, and vested at 200% of the original grant based on performance metrics and continued service.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects routine stock transactions related to executive compensation. The vesting of PRSUs at 200% is a slightly positive indicator.

Positives

• The vesting of PRSUs at 200% indicates strong performance by the company, as these units were subject to performance-based metrics.

Industry Context

This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The vesting of performance-based restricted stock units at 200% suggests that the company has met certain performance targets, which is generally positive for shareholders.

Key Dates